title: Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research.
abstract: Autoimmune liver diseases (AILD) are rare diseases with a reported prevalence of less than 50 per 100 000 population. As the research landscape and our understanding of AILDs and liver transplantation evolves, there remain areas of unmet needs. One of these areas of unmet needs is prevention of disease recurrence after liver transplantation. Disease recurrence is not an insignificant event because allograft loss with the need for retransplantation can occur. Patients transplanted for AILD are more likely to experience acute rejection compared to those transplanted for non-AILD, and the reason(s) behind this observation is unclear. Tasks for the future include a better understanding of the pathogenesis of AILD, definition of the precise pathogenetic mechanisms of recurrent AILD, and development of strategies that can identify recipients at risk for disease recurrence. Importantly, the role of crosstalk between alloimmune responses and autoimmune responses in AILD is an important area that needs further study.This article reviews the relevant literature of de novo autoimmune hepatitis, recurrent autoimmune hepatitis, recurrent primary sclerosing cholangitis, and recurrent primary biliary cirrhosis in terms of the clinical entity, the scientific advancements, and future scientific goals to enhance our understanding of these diseases.
authors.affiliation: 1 Section of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT.2 Yale New Haven Transplantation Center, New Haven, CT.
authors.forename: Catherine
authors.initials: C
authors.lastname: Edmunds
authors.forename: Udeme D
authors.initials: UD
authors.lastname: Ekong
mesh_terms: D064591:Allografts; D000818:Animals; D006084:Graft Rejection / Q000276:immunology / Q000601:surgery; D019693:Hepatitis, Autoimmune / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000601:surgery*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects; D012008:Recurrence; D012086:Reoperation; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome